Rockwell Med Inc Financials
This page shows Rockwell Med Inc (RMTI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Rockwell Med Inc has an operating margin of 0.6%, meaning the company retains $1 of operating profit per $100 of revenue. This below-average margin results in a low score of 3/100, suggesting thin profitability after operating expenses. This is up from -8.0% the prior year.
Rockwell Med Inc's revenue surged 21.4% year-over-year to $101.5M, reflecting rapid business expansion. This strong growth earns a score of 90/100.
Rockwell Med Inc carries a low D/E ratio of 0.26, meaning only $0.26 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 2.63, Rockwell Med Inc holds $2.63 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 85/100.
Rockwell Med Inc's free cash flow margin of 3.1% results in a low score of 16/100. Capital expenditures of $1.0M absorb a large share of operating cash flow.
Rockwell Med Inc scores -6.26, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($41.4M) relative to total liabilities ($26.6M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Rockwell Med Inc passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Rockwell Med Inc generates $-8.75 in operating cash flow ($4.2M OCF vs -$480K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Rockwell Med Inc earns $0.5 in operating income for every $1 of interest expense ($608K vs $1.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Rockwell Med Inc generated $101.5M in revenue in fiscal year 2024. This represents an increase of 21.4% from the prior year.
Rockwell Med Inc's EBITDA was $2.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 153.3% from the prior year.
Rockwell Med Inc generated $3.2M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 132.9% from the prior year.
Rockwell Med Inc reported -$480K in net income in fiscal year 2024. This represents an increase of 94.3% from the prior year.
Rockwell Med Inc earned $-0.03 per diluted share (EPS) in fiscal year 2024. This represents an increase of 91.9% from the prior year.
Rockwell Med Inc held $15.7M in cash against $8.5M in long-term debt as of fiscal year 2024.
Rockwell Med Inc had 34M shares outstanding in fiscal year 2024. This represents an increase of 16.9% from the prior year.
Rockwell Med Inc's gross margin was 17.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 6.8 percentage points from the prior year.
Rockwell Med Inc's operating margin was 0.6% in fiscal year 2024, reflecting core business profitability. This is up 8.6 percentage points from the prior year.
Rockwell Med Inc's net profit margin was -0.5% in fiscal year 2024, showing the share of revenue converted to profit. This is up 9.6 percentage points from the prior year.
Rockwell Med Inc invested $19K in research and development in fiscal year 2024. This represents a decrease of 98.3% from the prior year.
Rockwell Med Inc invested $1.0M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 256.0% from the prior year.
RMTI Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.9M-0.9% | $16.1M-15.0% | $18.9M-23.3% | $24.7M-4.5% | $25.8M+13.9% | $22.7M+2.6% | $22.1M-7.1% | $23.8M |
| Cost of Revenue | $13.7M+0.6% | $13.6M-14.5% | $15.9M-24.5% | $21.0M-1.2% | $21.3M+8.5% | $19.6M+2.0% | $19.2M-10.9% | $21.6M |
| Gross Profit | $2.3M-9.2% | $2.5M-17.7% | $3.0M-16.2% | $3.6M-20.2% | $4.5M+48.5% | $3.1M+6.8% | $2.9M+30.3% | $2.2M |
| R&D Expenses | $0 | $0 | $0-100.0% | $1K | $0-100.0% | $18K-89.3% | $168K-66.0% | $494K |
| SG&A Expenses | $3.3M+1.4% | $3.3M-11.1% | $3.7M+11.6% | $3.3M-4.1% | $3.4M-8.7% | $3.8M+39.4% | $2.7M-6.3% | $2.9M |
| Operating Income | -$1.6M-17.4% | -$1.3M+0.8% | -$1.4M-162.0% | -$519K-200.8% | $515K+138.9% | -$1.3M-142.0% | -$547K+68.5% | -$1.7M |
| Interest Expense | $285K+3.3% | $276K-0.4% | $277K-4.2% | $289K+24.6% | $232K-46.2% | $431K-61.1% | $1.1M+169.6% | $411K |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$1.8M-17.5% | -$1.5M+1.5% | -$1.5M-100.4% | -$756K-320.4% | $343K+119.8% | -$1.7M-14.5% | -$1.5M+19.2% | -$1.9M |
| EPS (Diluted) | $-0.050.0% | $-0.05-25.0% | $-0.04-100.0% | $-0.02-300.0% | $0.01+116.7% | $-0.06-200.0% | $-0.02+71.4% | $-0.07 |
RMTI Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $57.5M+9.2% | $52.6M-2.5% | $54.0M-8.9% | $59.2M+11.7% | $53.0M+4.5% | $50.7M-2.8% | $52.2M-0.8% | $52.6M |
| Current Assets | $37.5M+18.7% | $31.6M-4.3% | $33.0M-10.8% | $37.0M+24.5% | $29.8M+11.5% | $26.7M-7.2% | $28.8M+2.1% | $28.2M |
| Cash & Equivalents | $13.6M+9.0% | $12.5M+9.6% | $11.4M-27.3% | $15.7M+32.0% | $11.9M+78.6% | $6.6M-26.1% | $9.0M+15.8% | $7.8M |
| Inventory | $4.0M-4.7% | $4.2M-17.5% | $5.0M-12.7% | $5.8M-1.8% | $5.9M-3.1% | $6.1M+3.4% | $5.9M+7.0% | $5.5M |
| Accounts Receivable | $8.3M+3.0% | $8.1M-16.4% | $9.7M+16.6% | $8.3M-23.5% | $10.8M-2.3% | $11.1M+1.8% | $10.9M+16.5% | $9.4M |
| Goodwill | $921K0.0% | $921K0.0% | $921K0.0% | $921K0.0% | $921K0.0% | $921K0.0% | $921K0.0% | $921K |
| Total Liabilities | $20.5M-7.9% | $22.2M-1.0% | $22.4M-15.7% | $26.6M-9.8% | $29.5M-1.8% | $30.1M-2.6% | $30.9M-0.7% | $31.1M |
| Current Liabilities | $9.6M-12.5% | $10.9M-2.3% | $11.2M-20.5% | $14.1M-5.4% | $14.9M-0.4% | $14.9M-10.1% | $16.6M-22.3% | $21.4M |
| Long-Term Debt | $8.7M+1.0% | $8.6M+1.0% | $8.6M+1.0% | $8.5M+2.1% | $8.3M+0.4% | $8.3M-0.3% | $8.3M+149.0% | $3.3M |
| Total Equity | $37.0M+21.7% | $30.4M-3.5% | $31.5M-3.3% | $32.6M+38.7% | $23.5M+13.8% | $20.6M-3.0% | $21.3M-1.1% | $21.5M |
| Retained Earnings | -$402.4M-0.4% | -$400.7M-0.4% | -$399.2M-0.4% | -$397.7M+0.2% | -$398.6M+0.1% | -$398.9M-0.4% | -$397.2M-0.4% | -$395.7M |
RMTI Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.3M-170.9% | $1.8M+152.9% | -$3.5M-503.1% | $865K-40.0% | $1.4M+160.6% | -$2.4M-5434.9% | -$43K+98.9% | -$3.8M |
| Capital Expenditures | $229K+39.6% | $164K+160.3% | $63K-84.1% | $395K+38.1% | $286K+105.8% | $139K+223.3% | $43K | N/A |
| Free Cash Flow | -$1.5M-191.4% | $1.7M+147.3% | -$3.5M-855.3% | $470K-59.3% | $1.2M+145.9% | -$2.5M-2829.1% | -$86K | N/A |
| Investing Cash Flow | -$4.3M-4083.5% | -$103K-10200.0% | -$1K+99.7% | -$332K-119.3% | $1.7M+1335.3% | -$139K-106.9% | $2.0M+119.5% | -$10.3M |
| Financing Cash Flow | $6.7M+1137.5% | -$650K+17.0% | -$783K-128.0% | $2.8M+35.2% | $2.1M+1060.1% | $178K+124.0% | -$742K-105.8% | $12.8M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
RMTI Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 14.3%-1.3pp | 15.6%-0.5pp | 16.1%+1.4pp | 14.7%-2.9pp | 17.6%+4.1pp | 13.5%+0.5pp | 13.0%+3.7pp | 9.3% |
| Operating Margin | -10.0%-1.6pp | -8.4%-1.2pp | -7.2%-5.1pp | -2.1%-4.1pp | 2.0%+7.8pp | -5.8%-3.4pp | -2.5%+4.8pp | -7.3% |
| Net Margin | -11.0%-1.7pp | -9.3%-1.3pp | -8.0%-4.9pp | -3.1%-4.4pp | 1.3%+9.0pp | -7.6%-0.8pp | -6.8%+1.0pp | -7.9% |
| Return on Equity | N/A | N/A | N/A | 5.7%+4.3pp | 1.5% | N/A | N/A | N/A |
| Return on Assets | -3.0%-0.2pp | -2.8%-0.0pp | -2.8%-1.5pp | -1.3%-1.9pp | 0.7%+4.1pp | -3.4%-0.5pp | -2.9%+0.7pp | -3.6% |
| Current Ratio | 3.92+1.0 | 2.89-0.1 | 2.95+0.3 | 2.63+0.6 | 2.00+0.2 | 1.79+0.1 | 1.73+0.4 | 1.32 |
| Debt-to-Equity | 0.24-0.0 | 0.28+0.0 | 0.27+0.0 | 0.26-0.1 | 0.35-0.0 | 0.40+0.0 | 0.39+0.2 | 0.15 |
| FCF Margin | -9.6%-20.1pp | 10.4%+29.2pp | -18.8%-20.7pp | 1.9%-2.6pp | 4.5%+15.6pp | -11.1%-10.7pp | -0.4% | N/A |
Similar Companies
Frequently Asked Questions
What is Rockwell Med Inc's annual revenue?
Rockwell Med Inc (RMTI) reported $101.5M in total revenue for fiscal year 2024. This represents a 21.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Rockwell Med Inc's revenue growing?
Rockwell Med Inc (RMTI) revenue grew by 21.4% year-over-year, from $83.6M to $101.5M in fiscal year 2024.
Is Rockwell Med Inc profitable?
No, Rockwell Med Inc (RMTI) reported a net income of -$480K in fiscal year 2024, with a net profit margin of -0.5%.
What is Rockwell Med Inc's earnings per share (EPS)?
Rockwell Med Inc (RMTI) reported diluted earnings per share of $-0.03 for fiscal year 2024. This represents a 91.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Rockwell Med Inc's EBITDA?
Rockwell Med Inc (RMTI) had EBITDA of $2.8M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Rockwell Med Inc have?
As of fiscal year 2024, Rockwell Med Inc (RMTI) had $15.7M in cash and equivalents against $8.5M in long-term debt.
What is Rockwell Med Inc's gross margin?
Rockwell Med Inc (RMTI) had a gross margin of 17.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Rockwell Med Inc's operating margin?
Rockwell Med Inc (RMTI) had an operating margin of 0.6% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Rockwell Med Inc's net profit margin?
Rockwell Med Inc (RMTI) had a net profit margin of -0.5% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Rockwell Med Inc's free cash flow?
Rockwell Med Inc (RMTI) generated $3.2M in free cash flow during fiscal year 2024. This represents a 132.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Rockwell Med Inc's operating cash flow?
Rockwell Med Inc (RMTI) generated $4.2M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Rockwell Med Inc's total assets?
Rockwell Med Inc (RMTI) had $59.2M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Rockwell Med Inc's capital expenditures?
Rockwell Med Inc (RMTI) invested $1.0M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Rockwell Med Inc spend on research and development?
Rockwell Med Inc (RMTI) invested $19K in research and development during fiscal year 2024.
How many shares does Rockwell Med Inc have outstanding?
Rockwell Med Inc (RMTI) had 34M shares outstanding as of fiscal year 2024.
What is Rockwell Med Inc's current ratio?
Rockwell Med Inc (RMTI) had a current ratio of 2.63 as of fiscal year 2024, which is generally considered healthy.
What is Rockwell Med Inc's debt-to-equity ratio?
Rockwell Med Inc (RMTI) had a debt-to-equity ratio of 0.26 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Rockwell Med Inc's return on assets (ROA)?
Rockwell Med Inc (RMTI) had a return on assets of -0.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Rockwell Med Inc's Altman Z-Score?
Rockwell Med Inc (RMTI) has an Altman Z-Score of -6.26, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Rockwell Med Inc's Piotroski F-Score?
Rockwell Med Inc (RMTI) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Rockwell Med Inc's earnings high quality?
Rockwell Med Inc (RMTI) has an earnings quality ratio of -8.75x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Rockwell Med Inc cover its interest payments?
Rockwell Med Inc (RMTI) has an interest coverage ratio of 0.5x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Rockwell Med Inc?
Rockwell Med Inc (RMTI) scores 59 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.